Launched in 2004, the Broad Institute is an unprecedented scientific undertaking that seeks to fulfill the promise of genomics for medicine by empowering creative and energetic scientists from many institutions and backgrounds to work together to build critical genomic research tools, share them with the scientific community, and pioneer their application to the study and treatment of disease.
The Broad Institute is a partnership of the Massachusetts Institute of Technology, Harvard University and its affiliated hospitals, and the Whitehead Institute for Biomedical Research, and is governed jointly by MIT and Harvard. The Broad Institute includes investigators from all of its partner institutions, many of whom are faculty members at MIT, Whitehead, Harvard University, or Harvard Medical School. Currently there are six core faculty members, with their primary labs located at Broad, and 110 associate members, with their primary labs located at one of the universities or hospitals.
The Broad Institute research labs are at 7 Cambridge Center (MIT Building NE30), across the street from MIT's Biology Department and adjacent to the Whitehead Institute. Broad's genome sequencing laboratory and its staff are at 320 Charles Street (MIT Building NE125).